T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease

Hidenori Hattori, Daisuke Ito, Norio Tanahashi, Mitsuru Murata, Ikuo Saito, Kiyoaki Watanabe, Norihiro Suzuki

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The contribution to atherosclerosis of two CX3CR1 single nucleotide polymorphisms, V249I and T280M has been recently reported. The atherosclerosis of intracranial vessels is thought to be the major pathological mechanism of ischemic stroke. In this study, we investigated the risk of ischemic stroke associated with fractalkine receptor CX3CR1 polymorphisms. We investigated the T280M and V249I mutations in the CX3CR1 gene in 235 Japanese patients with ischemic cerebrovascular disease (CVD) and 306 age- and sex-matched healthy controls. Polymerase chain reaction and restriction fragment length polymorphism were used for genotyping. There was no significant difference in both polymorphisms between patients with ischemic CVD and controls (VV versus II + VI, p = 0.83; TT versus MM + TM, p = 0.66). The I and M allele frequencies were not significantly different between CVD patients and controls: odds ratio (OR) = 0.89 (95% confidence interval (CI) = 0.50-1.60, p = 0.70) and OR = 1.19 (95% CI = 0.71-2.00, p = 0.51), respectively. We found eight of nine possible combined genotypes, including a new haplotype V249-M280, in Japanese. Our results show that these CX3CR1 gene polymorphisms are not associated with an increased risk for ischemic CVD in the Japanese population.

Original languageEnglish
Pages (from-to)132-135
Number of pages4
JournalNeuroscience Letters
Volume374
Issue number2
DOIs
Publication statusPublished - 2005 Feb 10

Fingerprint

Cerebrovascular Disorders
Stroke
Odds Ratio
Intracranial Arteriosclerosis
Confidence Intervals
Gene Frequency
Restriction Fragment Length Polymorphisms
Haplotypes
Genes
Single Nucleotide Polymorphism
Atherosclerosis
Genotype
Polymerase Chain Reaction
Mutation
V28 receptor
Population

Keywords

  • Atherosclerosis
  • CX3CR1
  • Fractalkine
  • Ischemic stroke
  • Polymorphism

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease. / Hattori, Hidenori; Ito, Daisuke; Tanahashi, Norio; Murata, Mitsuru; Saito, Ikuo; Watanabe, Kiyoaki; Suzuki, Norihiro.

In: Neuroscience Letters, Vol. 374, No. 2, 10.02.2005, p. 132-135.

Research output: Contribution to journalArticle

Hattori, Hidenori ; Ito, Daisuke ; Tanahashi, Norio ; Murata, Mitsuru ; Saito, Ikuo ; Watanabe, Kiyoaki ; Suzuki, Norihiro. / T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease. In: Neuroscience Letters. 2005 ; Vol. 374, No. 2. pp. 132-135.
@article{4e4eca0689df438aa6d5c8478fefcab8,
title = "T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease",
abstract = "The contribution to atherosclerosis of two CX3CR1 single nucleotide polymorphisms, V249I and T280M has been recently reported. The atherosclerosis of intracranial vessels is thought to be the major pathological mechanism of ischemic stroke. In this study, we investigated the risk of ischemic stroke associated with fractalkine receptor CX3CR1 polymorphisms. We investigated the T280M and V249I mutations in the CX3CR1 gene in 235 Japanese patients with ischemic cerebrovascular disease (CVD) and 306 age- and sex-matched healthy controls. Polymerase chain reaction and restriction fragment length polymorphism were used for genotyping. There was no significant difference in both polymorphisms between patients with ischemic CVD and controls (VV versus II + VI, p = 0.83; TT versus MM + TM, p = 0.66). The I and M allele frequencies were not significantly different between CVD patients and controls: odds ratio (OR) = 0.89 (95{\%} confidence interval (CI) = 0.50-1.60, p = 0.70) and OR = 1.19 (95{\%} CI = 0.71-2.00, p = 0.51), respectively. We found eight of nine possible combined genotypes, including a new haplotype V249-M280, in Japanese. Our results show that these CX3CR1 gene polymorphisms are not associated with an increased risk for ischemic CVD in the Japanese population.",
keywords = "Atherosclerosis, CX3CR1, Fractalkine, Ischemic stroke, Polymorphism",
author = "Hidenori Hattori and Daisuke Ito and Norio Tanahashi and Mitsuru Murata and Ikuo Saito and Kiyoaki Watanabe and Norihiro Suzuki",
year = "2005",
month = "2",
day = "10",
doi = "10.1016/j.neulet.2004.10.042",
language = "English",
volume = "374",
pages = "132--135",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease

AU - Hattori, Hidenori

AU - Ito, Daisuke

AU - Tanahashi, Norio

AU - Murata, Mitsuru

AU - Saito, Ikuo

AU - Watanabe, Kiyoaki

AU - Suzuki, Norihiro

PY - 2005/2/10

Y1 - 2005/2/10

N2 - The contribution to atherosclerosis of two CX3CR1 single nucleotide polymorphisms, V249I and T280M has been recently reported. The atherosclerosis of intracranial vessels is thought to be the major pathological mechanism of ischemic stroke. In this study, we investigated the risk of ischemic stroke associated with fractalkine receptor CX3CR1 polymorphisms. We investigated the T280M and V249I mutations in the CX3CR1 gene in 235 Japanese patients with ischemic cerebrovascular disease (CVD) and 306 age- and sex-matched healthy controls. Polymerase chain reaction and restriction fragment length polymorphism were used for genotyping. There was no significant difference in both polymorphisms between patients with ischemic CVD and controls (VV versus II + VI, p = 0.83; TT versus MM + TM, p = 0.66). The I and M allele frequencies were not significantly different between CVD patients and controls: odds ratio (OR) = 0.89 (95% confidence interval (CI) = 0.50-1.60, p = 0.70) and OR = 1.19 (95% CI = 0.71-2.00, p = 0.51), respectively. We found eight of nine possible combined genotypes, including a new haplotype V249-M280, in Japanese. Our results show that these CX3CR1 gene polymorphisms are not associated with an increased risk for ischemic CVD in the Japanese population.

AB - The contribution to atherosclerosis of two CX3CR1 single nucleotide polymorphisms, V249I and T280M has been recently reported. The atherosclerosis of intracranial vessels is thought to be the major pathological mechanism of ischemic stroke. In this study, we investigated the risk of ischemic stroke associated with fractalkine receptor CX3CR1 polymorphisms. We investigated the T280M and V249I mutations in the CX3CR1 gene in 235 Japanese patients with ischemic cerebrovascular disease (CVD) and 306 age- and sex-matched healthy controls. Polymerase chain reaction and restriction fragment length polymorphism were used for genotyping. There was no significant difference in both polymorphisms between patients with ischemic CVD and controls (VV versus II + VI, p = 0.83; TT versus MM + TM, p = 0.66). The I and M allele frequencies were not significantly different between CVD patients and controls: odds ratio (OR) = 0.89 (95% confidence interval (CI) = 0.50-1.60, p = 0.70) and OR = 1.19 (95% CI = 0.71-2.00, p = 0.51), respectively. We found eight of nine possible combined genotypes, including a new haplotype V249-M280, in Japanese. Our results show that these CX3CR1 gene polymorphisms are not associated with an increased risk for ischemic CVD in the Japanese population.

KW - Atherosclerosis

KW - CX3CR1

KW - Fractalkine

KW - Ischemic stroke

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=11844282848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11844282848&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2004.10.042

DO - 10.1016/j.neulet.2004.10.042

M3 - Article

VL - 374

SP - 132

EP - 135

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -